ReciBioPharm (now Recipharm Advanced Bio) is the advanced therapies division of Recipharm, a global CDMO devoted to process development and GMP manufacturing for advanced therapeutics including xRNA therapies, viral vectors, microbial/live biotherapeutic products, and recombinant proteins. They offer end-to-end services from preclinical development to commercial manufacturing, with operations on two continents. They have partnerships with the University of Oxford, NewBiologix (AAV cell lines), LenioBio, and Hongene Biotech.
xRNA therapeutics manufacturing, plasmid DNA production, lipid nanoparticle formulation, AAV viral vector production, lentivirus manufacturing, cell/bacteria/virus banking, ATMP development and GMP manufacturing
4 sites worldwide
No reviews available yet.
No documents available.